There is a growing number of social simulation researchers who are employing different data mining and machine learning techniques to explore agent-based simulations.
The severity of ALS and the lack of effective therapeutic strategies are driving efforts to explore agents, applied either separately or in combination, to counteract disease symptoms.
In addition, because we also studied host factors, this system is applicable not only for studying the HBV life cycle, but also for exploring agent(s) that regulate HBV proliferation.
The exploring agents, denoted as scouts, are autonomously deployed using supporting agents, denoted as rangers.
Hence exploring agents modulating oxidative stress is an effective strategy in the treatment of both Type I and Type II diabetes.
A phase II trial about selumetinib in this setting prompted the development of two phase III trials exploring agents of the same class in recurrent or persistent LGSOC [68].
In this paper, the first in a two-part series, we explore an agent based solution approach to the multiperiod design of azeotropic separation systems.
If one is still to explore single agent antiangiogenic treatment, a situation of minimal residual disease following either cytoreductive surgery or cytotoxic treatment seems most appropriate to adequately assess the role of these agents in secondary cancer growth prevention.
In this article I will explore the agent-based modelling technique in depth.
We will explore the agents that seem to resist changes within this arena of education, or what constraints may be operating in terms of changing educational content.
Although endotoxemia is useful for investigating the complex cytokine cascades, more clinically relevant animal models are necessary to explore therapeutic agents for the treatment of human sepsis.
